See also this year's filing and all EDGAR filings for this company.
PDF Report 0000847464_2018_Spring_Pharmaceutical_Group_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000847464, Spring Pharmaceutical Group INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 18,477,966 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,042,758 |
| 2 | PropertyPlantAndEquipmentNet | 14,487,135 |
| 3 | remainder_Assets | 45,279,167 |
| 4 | LiabilitiesCurrent | 2,985,545 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 33,284,237 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,472,610 |
| 9 | ResearchAndDevelopmentExpense | 959,862 |
| 10 | remainder_Expenses | 15,362,632 |
| 11 | remainder_Revenues | 52,951,110 |
| 12 | remainder_NetIncome | -466 |
| 13 | remainder_ComprehensiveNetIncome | -4,755,016 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 90,287,026 |
| 1 | Liabilities | 2,985,545 |
| 2 | Expenses | 53,079,341 |
| 3 | Revenues | 52,951,110 |
| 4 | StockholdersEquity | 87,301,481 |
| 5 | NetIncome | -128,697 |
| 6 | ComprehensiveNetIncome | -2,506,205 |
| 7 | BaseVar | 102,029,252 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.03 |
| 9 | EconomicCapitalRatio | 4.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
